Jinling Xue possesses an interdisciplinary background in Environmental Microbiology and Human Health Risk Assessment, which she leverages to advance the field of virome research. Her work investigates the critical contributions of virome to both natural ecological circulations and the development of human autoimmune diseases, such as Type 2 Diabetes (T2D) and Graft-versus-Host Disease (GvHD). By utilizing multi-omics approaches and Deep-Learning-Based protein structural prediction, she has uncovered a series of novel bacteriophage-encoded genes that play pivotal roles in short-chain fatty acid biosynthesis (BCoAT) and long-chain hydrocarbon degradation (various Alkane Hydroxylases). Her current research focuses on expanding the understanding of microbial ecology and pathogenesis and also on opening new avenues for therapeutic interventions via phage-involved treatments.